Insulet Corp (PODD)
164.17
-3.08
(-1.84%)
USD |
NASDAQ |
Apr 25, 16:00
162.17
-2.00
(-1.22%)
After-Hours: 20:00
Insulet Profit Margin (Quarterly): 20.26% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.26% |
| September 30, 2023 | 11.99% |
| June 30, 2023 | 6.89% |
| March 31, 2023 | 6.65% |
| December 31, 2022 | 4.60% |
| September 30, 2022 | -1.53% |
| June 30, 2022 | -11.69% |
| March 31, 2022 | 9.41% |
| December 31, 2021 | 9.49% |
| September 30, 2021 | 4.57% |
| June 30, 2021 | -9.50% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | -6.95% |
| September 30, 2020 | 4.96% |
| June 30, 2020 | 6.36% |
| March 31, 2020 | -1.06% |
| December 31, 2019 | 2.39% |
| September 30, 2019 | 0.42% |
| June 30, 2019 | 0.79% |
| March 31, 2019 | 2.76% |
| December 31, 2018 | 6.00% |
| September 30, 2018 | 1.10% |
| June 30, 2018 | -1.36% |
| March 31, 2018 | -5.32% |
| December 31, 2017 | -5.23% |
| Date | Value |
|---|---|
| September 30, 2017 | -1.83% |
| June 30, 2017 | -7.08% |
| March 31, 2017 | -9.81% |
| December 31, 2016 | -8.80% |
| September 30, 2016 | -3.25% |
| June 30, 2016 | -4.81% |
| March 31, 2016 | -15.37% |
| December 31, 2015 | -32.61% |
| September 30, 2015 | -26.51% |
| June 30, 2015 | -25.49% |
| March 31, 2015 | -24.58% |
| December 31, 2014 | -35.62% |
| September 30, 2014 | -14.46% |
| June 30, 2014 | -40.42% |
| March 31, 2014 | -8.88% |
| December 31, 2013 | -3.65% |
| September 30, 2013 | -34.84% |
| June 30, 2013 | -17.50% |
| March 31, 2013 | -18.59% |
| December 31, 2012 | -17.63% |
| September 30, 2012 | -22.68% |
| June 30, 2012 | -28.36% |
| March 31, 2012 | -30.95% |
| December 31, 2011 | -30.38% |
| September 30, 2011 | -30.41% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-11.69%
Minimum
Jun 2022
20.26%
Maximum
Dec 2023
3.06%
Average
4.57%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 12.29% |
| Stryker Corp | 19.66% |
| Becton Dickinson & Co | 5.97% |
| Haemonetics Corp | 9.29% |
| Tandem Diabetes Care Inc | -15.25% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 35.90% |
| Return on Assets | 8.61% |
| Return on Invested Capital | 10.41% |
| Gross Profit Margin (Quarterly) | 70.85% |
| Operating Margin (Quarterly) | 20.87% |
| Return on Net Operating Assets | 13.42% |